Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aligos Therapeutics, Inc. (ALGS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/27/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 7.5% stake in Aligos Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| BAKER BROS. ADVISORS LP reports a 5.3% stake in Aligos Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 5.7% stake in Aligos Therapeutics, Inc. |
| 08/13/2021 |
SC 13G
| Logos Global Management LP reports a 6.7% stake in Aligos Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2021 |
SC 13G
| BLATT LAWRENCE reports a 6.7% stake in Aligos Therapeutics, Inc. |
| 02/11/2021 |
SC 13G
| Beigelman Leonid reports a 5.1% stake in Aligos Therapeutics, Inc. |
| 01/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/28/2020 |
SC 13G
| Vivo Capital VIII, LLC reports a 10.5% stake in Aligos Therapeutics, Inc. |
| 10/22/2020 |
SC 13G
| Wellington Biomedical Innovation Master Investors I L.P. reports a 5.3% stake in Aligos Therapeutics, Inc. |
|
|